{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T09:28:32Z","timestamp":1780824512785,"version":"3.54.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"am","delay-in-days":308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5-U01AI082051-02"],"award-info":[{"award-number":["5-U01AI082051-02"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"Department of Defense Chemical Biological Defense Program through the Defense Threat Reduction Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010201","name":"United States Army Medical Research Institute of Infectious Diseases","doi-asserted-by":"publisher","award":["13255634"],"award-info":[{"award-number":["13255634"]}],"id":[{"id":"10.13039\/100010201","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007770","name":"Ministry of Science and Technological Development of Serbia","doi-asserted-by":"publisher","award":["172008"],"award-info":[{"award-number":["172008"]}],"id":[{"id":"10.13039\/100007770","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018992","name":"Serbian Academy of Sciences and Arts","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018992","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejmech.2018.10.061","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T01:04:21Z","timestamp":1540947861000},"page":"32-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action"],"prefix":"10.1016","volume":"162","author":[{"given":"\u017divota","family":"Selakovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie P.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna P.","family":"Kota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Lazi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary","family":"Retterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Besch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha G.","family":"Panchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Soloveva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vantongreen A.","family":"Sean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wells B.","family":"Jay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Pavi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Verbi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branka","family":"Vasiljevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Kuehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen J.","family":"Duplantier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Bavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajini","family":"Mudhasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9975-2725","authenticated-orcid":false,"given":"Bogdan A.","family":"\u0160olaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.10.061_bib4","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3390\/v4101878","article-title":"Forty-five years of Marburg virus research","volume":"4","author":"Brauburger","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2018.10.061_bib5","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.3390\/v6041759","article-title":"Filoviruses in bats: current knowledge and future directions","volume":"6","author":"Olival","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2018.10.061_bib6","doi-asserted-by":"crossref","first-page":"15.1","DOI":"10.1146\/annurev-pathol-052016-100506","article-title":"The pathogenesis of Ebola virus disease","volume":"12","author":"Baseler","year":"2017","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ejmech.2018.10.061_bib7","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJMoa1410863","article-title":"Chimpanzee adenovirus vector Ebola vaccine","volume":"376","author":"Ledgerwood","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2018.10.061_bib8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2018.10.061_bib9","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/jama.2016.20644","article-title":"Immune responses to novel Adenovirus type 26 and modified vaccinia virus Ankara-vectored Ebola vaccines at 1 Year","volume":"317","author":"Winslow","year":"2017","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.ejmech.2018.10.061_bib10","article-title":"Research during Ebola vaccine trial: it's complicated","author":"Cohen","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.10.061_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","article-title":"Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model","volume":"105","author":"Oestereich","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2018.10.061_bib12","article-title":"Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea","volume":"13","author":"Sissoko","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejmech.2018.10.061_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005471","article-title":"FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection","volume":"5","author":"Johansen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2018.10.061_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature18615","article-title":"Toremifene interacts with and destabilizes the Ebola virus glycoprotein","volume":"535","author":"Zhao","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.10.061_bib15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"Warren","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.10.061_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.10.061_bib17","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/v4081279","article-title":"A\u00a0limited structural modification results in a significantly more efficacious diazachrysene-based filovirus inhibitor","volume":"4","author":"Selakovi\u0107","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2018.10.061_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060579","article-title":"A\u00a0systematic screen of FDA-approved drugs for inhibitors of biological threat agents","volume":"8","author":"Madrid","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2018.10.061_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/76780c06-ac81-48a3-8cce-509da6858fe5","article-title":"Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection","volume":"8","author":"Shoemaker","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2018.10.061_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa5597","article-title":"A\u00a0screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity","volume":"7","author":"Johansen","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2018.10.061_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/019262339702500111","article-title":"Cationic amphiphilic drug-induced phospholipidosis","volume":"25","author":"Halliwell","year":"1997","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejmech.2018.10.061_bib22","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1110656","article-title":"Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection","volume":"308","author":"Chandran","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.10.061_bib23","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/JVI.80.8.4174-4178.2006","article-title":"Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein","volume":"80","author":"Schornberg","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2018.10.061_bib24","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/JVI.05708-11","article-title":"Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change","volume":"86","author":"Brecher","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2018.10.061_bib25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter Niemann-Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.10.061_bib26","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature10380","article-title":"Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection","volume":"477","author":"C\u00f4t\u00e9","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.10.061_bib27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1021\/acsinfecdis.5b00030","article-title":"Evaluation of Ebola virus inhibitors for drug repurposing","volume":"1","author":"Madrid","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.10.061_bib28","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1099\/jgv.0.000309","article-title":"Chloroquine inhibited Ebola virus replication in\u00a0vitro but failed to protect against infection and disease in the in\u00a0vivo Guinea pig model","volume":"96","author":"Dowall","year":"2015","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.ejmech.2018.10.061_bib29","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3201\/eid2106.150176","article-title":"Lack of protection against Ebola virus from chloroquine in mice and hamsters","volume":"21","author":"Falzarano","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.10.061_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504605","article-title":"Effect of Artesunate-Amodiaquine on mortality related to Ebola virus disease","volume":"374","author":"Gignoux","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2018.10.061_bib31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1021\/acsinfecdis.5b00028","article-title":"Anti-Ebola activity of diazachrysene small molecules","volume":"1","author":"Selakovi\u0107","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.10.061_bib32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.drudis.2009.07.014","article-title":"The impact of aromatic ring count on compound developability - are too many aromatic rings a liability in drug design?","volume":"14","author":"Ritchie","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2018.10.061_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mrgentox.2005.06.006","article-title":"Nitrogen-substitution effects on the mutagenicity and cytochrome P450 isoform-selectivity of chrysene analogs","volume":"586","author":"Yamada","year":"2005","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ejmech.2018.10.061_bib34","unstructured":"A. Johns, R. Alan Porter, Cinnamide derivatives as orexin-1 receptors antagonists, Int. Patent 2000047576, August 17, 2000."},{"key":"10.1016\/j.ejmech.2018.10.061_bib35","unstructured":"A.C. Castro, C.A. Evans, S. Janardanannair, A. Lescarbeau, T. Liu, D.A. Snyder, M.R. Tremblay, P. Ren, Y. Liu, L. Li, K. Chan, Heterocyclic compounds and uses thereof, Int. Patent 2013012915, January 24, 2013."},{"key":"10.1016\/j.ejmech.2018.10.061_bib36","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/jo00401a010","article-title":"Centrosymmetric 1,5-naphthyridine derivatives: synthesis, tautomerism, and thermal rearrangements","volume":"43","author":"Brown","year":"1978","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2018.10.061_bib37","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1021\/op049899l","article-title":"Development of an efficient and scalable process of a respiratory syncytial virus inhibitor","volume":"8","author":"Provencal","year":"2004","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ejmech.2018.10.061_bib38","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1021\/ic302101c","article-title":"Manganese salen complexes with acid\u2212base catalytic auxiliary: functional mimetics of catalase","volume":"52","author":"Noritake","year":"2013","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2018.10.061_bib39","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/1087057110374357","article-title":"Development of high-content imaging assays for lethal viral pathogens","volume":"15","author":"Panchal","year":"2010","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.ejmech.2018.10.061_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/1087057114556253","article-title":"High-content image-based screening of a signal transduction pathway inhibitor small-molecule library against highly pathogenic RNA viruses","volume":"20","author":"Mudhasani","year":"2015","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.ejmech.2018.10.061_bib41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.antiviral.2009.06.001","article-title":"Development of a broad-spectrum antiviral with activity against Ebola virus","volume":"83","author":"Aman","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2018.10.061_bib42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/ml300370k","article-title":"Inhibition of Ebola virus infection: identification of Niemann-Pick C1 as the target by optimization of a chemical probe","volume":"4","author":"Lee","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.10.061_bib43","unstructured":"Department of Defense, ADMET Center at USAMRICD, Gunpowder, Maryland, USA."},{"key":"10.1016\/j.ejmech.2018.10.061_bib44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10895-010-0735-9","article-title":"Binding of an anti-inflammatory drug lornoxicam with blood proteins: insights from spectroscopic investigations","volume":"21","author":"Punith","year":"2011","journal-title":"J.\u00a0Fluoresc."},{"key":"10.1016\/j.ejmech.2018.10.061_bib45","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/j.bmc.2008.01.053","article-title":"Selective plasma protein binding of antimalarial drugs to \u03b11-acid glycoprotein","volume":"16","author":"Zsila","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.10.061_bib46","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1021\/acs.jmedchem.7b00008","article-title":"Antimalarial inhibitors targeting serine hydroxymethyltransferase (SHMT) with in\u00a0vivo efficacy and analysis of their binding mode based on X-ray cocrystal structures","volume":"60","author":"Schwertz","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.10.061_bib47","unstructured":"ACD\/Labs Release 12.0, ACD\/PhysChem Build 39480 - Advanced Chemistry Development, Inc. 8 King Street East, Suite 107, Toronto, Ontario, Canada M5C 1B5."},{"key":"10.1016\/j.ejmech.2018.10.061_bib48","series-title":"ADMET Predictor, Simulations Plus, Inc., Lancaster, CA, USA, Ver. 8.5","year":"2017"},{"key":"10.1016\/j.ejmech.2018.10.061_bib49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1021\/ci500585w","article-title":"Best of both worlds: combining pharma data and state of the art modeling technology to improve in silico pKa prediction","volume":"55","author":"Fraczkiewicz","year":"2014","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2018.10.061_bib50","series-title":"Principles of Pharmacology: the Pathophysiologic Basis of Drug Therapy","first-page":"147","article-title":"Local anesthetic pharmacology","author":"Schulman","year":"2012"},{"key":"10.1016\/j.ejmech.2018.10.061_bib51","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.vascn.2016.12.002","article-title":"A\u00a0rapid assessment for predicting drug-induced hepatotoxicity using zebrafish","volume":"84","author":"Zhang","year":"2017","journal-title":"J.\u00a0Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejmech.2018.10.061_bib52","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/515386","article-title":"A\u00a0mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever","volume":"178","author":"Bray","year":"1998","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.10.061_bib53","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1128\/AAC.01315-09","article-title":"Antiviral activity of a small-molecule inhibitor of filovirus infection","volume":"54","author":"Warren","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.10.061_bib54","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.3390\/v4112806","article-title":"Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections","volume":"4","author":"Iversen","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2018.10.061_bib55","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.antiviral.2013.03.023","article-title":"Small molecule inhibitors of ER alpha-glucosidases are active against multiple hemorrhagic fever viruses","volume":"98","author":"Chang","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2018.10.061_bib56","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1021\/mp200641e","article-title":"Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction","volume":"9","author":"Funk","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2018.10.061_bib57","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1128\/JVI.03398-14","article-title":"Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step","volume":"89","author":"Mingo","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2018.10.061_bib58","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/JVI.01832-09","article-title":"A\u00a0forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry","volume":"84","author":"Wong","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2018.10.061_bib59","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1034\/j.1600-0854.2003.00090.x","article-title":"Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses","volume":"4","author":"Sieczkarski","year":"2003","journal-title":"Traffic"},{"key":"10.1016\/j.ejmech.2018.10.061_bib60","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1021\/jm100938u","article-title":"A\u00a0chemotype that inhibits three unrelated pathogenic targets: the botulinum neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus","volume":"54","author":"Opsenica","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.10.061_bib61","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1128\/JVI.72.4.3155-3160.1998","article-title":"Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines","volume":"72","author":"Wool-Lewis","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2018.10.061_bib62","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-4684-5442-0_16","article-title":"Endosome acidification and the pathways of receptor-mediated endocytosis","volume":"225","author":"Maxfield","year":"1987","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2018.10.061_bib63","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jcp.1041630116","article-title":"Bafilomycin A1 inhibits lysosomal, phagosomal, and plasma membrane H(+)-ATPase and induces lysosomal enzyme secretion in macrophages","volume":"163","author":"Tapper","year":"1995","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.ejmech.2018.10.061_bib64","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1242\/jcs.195057","article-title":"Ratiometric analysis of Acridine Orange staining in the study of acidic organelles and autophagy","volume":"129","author":"Thome","year":"2016","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.ejmech.2018.10.061_bib65","doi-asserted-by":"crossref","first-page":"13476","DOI":"10.1038\/srep13476","article-title":"Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting","volume":"5","author":"Zilbermintz","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2018.10.061_bib66","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cell.2004.11.046","article-title":"Growth factor regulation of autophagy and cell survival in the absence of apoptosis","volume":"120","author":"Lum","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2018.10.061_bib67","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4161\/auto.28594","article-title":"Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib","volume":"10","author":"Goodall","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.ejmech.2018.10.061_bib68","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1016\/j.bbagen.2013.05.005","article-title":"Albumin-drug interaction and its clinical implication","volume":"1830","author":"Yamasaki","year":"2013","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ejmech.2018.10.061_bib69","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1081\/DMR-100104402","article-title":"Human alpha-1-glycoprotein and its interactions with drugs","volume":"33","author":"Israili","year":"2001","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejmech.2018.10.061_bib70","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nrd3287","article-title":"The effect of plasma protein binding on in\u00a0vivo efficacy: misconceptions in drug discovery","volume":"9","author":"Smith","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.10.061_bib71","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1038\/emi.2014.88","article-title":"Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs","volume":"3","author":"Kouznetsova","year":"2014","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.ejmech.2018.10.061_bib72","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/v8080206","article-title":"Clomiphene and its isomers block Ebola virus particle entry and infection with similar potency: potential therapeutic implications","volume":"8","author":"Nelson","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2018.10.061_bib73","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/14787210.2017.1305888","article-title":"Antiviral activity of cationic amphiphilic drugs","volume":"15","author":"Salata","year":"2017","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ejmech.2018.10.061_bib74","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.tiv.2010.12.010","article-title":"A\u00a0high content screening assay for identifying lysosomotropic compounds","volume":"25","author":"Nadanaciva","year":"2011","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejmech.2018.10.061_bib75","article-title":"Lysosomal adaptation: how cells respond to lysosomotropic compounds","volume":"12","author":"Lu","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2018.10.061_bib76","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/jps.23949","article-title":"Amine-containing molecules and the induction of an expanded lysosomal volume phenotype: a structure-activity relationship study","volume":"103","author":"Logan","year":"2014","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2018.10.061_bib77","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1126\/science.1258758","article-title":"Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment","volume":"347","author":"Sakurai","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.10.061_bib78","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1091\/mbc.e13-08-0447","article-title":"The HOPS complex mediates autophagosome-lysosome fusion through interaction with syntaxin 17","volume":"25","author":"Jiang","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejmech.2018.10.061_bib79","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbalip.2012.08.013","article-title":"Drug induced phospholipidosis: an acquired lysosomalstorage disorder","volume":"1831","author":"Shayman","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2018.10.061_bib80","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2018.10.061_bib81","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1091\/mbc.e07-10-1092","article-title":"Induction of autophagy during extracellular matrix detachment promotes cell survival","volume":"19","author":"Fung","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejmech.2018.10.061_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003095","article-title":"Highcontent image-based screening of a protease inhibitor library reveals compounds broadly active against Rift Valley fever virus and other highly pathogenic RNA viruses","volume":"8","author":"Mudhasani","year":"2014","journal-title":"PLoS Neglected Trop. Dis."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418309383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418309383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:47:37Z","timestamp":1759326457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418309383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":79,"alternative-id":["S0223523418309383"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.10.061","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.10.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}